Yan Yi1, Lu Lin1, Yining Wang1, Jian Cao1, Lingyan Kong1, Jing An2, Tianjing Zhang2, and Bruce Spottiswoode3
1Peking Union Medical College Hospital, Beijing, China, People's Republic of, 2Siemens Shenzhen Magnetic Resonance Ltd., beijing, China., Beijing, China, People's Republic of, 3MR Research and Development, Siemens Healthcare, Chigago, IL, United States
Synopsis
The study aim was to explore the diagnostic
value of ECV for cardiac amyloidosis calculated
by 5 min post-contrast T1-mapping compared
with conventional 15-20
min post-contrast T1
mapping. The results showed ECV calculated by 5min post-contrast T1 mapping had similarly
promising diagnosis value for cardiac amyloidosis compared with 15-20 min
post-contrast T1 mapping. Purpose: Cardiac involvement in systemic light-chain
(AL) amyloidosis is caused by the extracellular deposition of misfolded AL
immunoglobulin and carries a poor prognosis. Cardiac magnetic resonance (CMR)
T1 mapping and extracellular volume (ECV) measurements have been proved to have advantages over late gadolinium enhancement
(LGE) for early diagnosis and quantification of amyloid burden [1]. Previous research showed a
dynamic equilibrium between myocardial and blood gadolinium concentrations
could be reached from 5 to 20 minutes (min) after gadolinium injection [2]. The aim of this study
was to explore the diagnostic value of ECV for cardiac amyloidosis calculated by 5 min post-contrast T1-mapping compared with conventional 15-20 min post-contrast T1
mapping.
Methods: The study received local ethical approval
and all patients gave written informed consent. The amyloidosis group included
patients diagnosed of systemic AL amyloidosis with histology proof and definite
clinical cardiac involvement. The control group included patients with neither
clinical evidence of infiltrative cardiomyopathy nor CMR myocardial LGE.
All the patients underwent a standardized bolus contrast-enhanced CMR (3.0T)
imaging composed of native, 5min and 15-20min post-contrast T1 mapping (modified
Look-Lockers inversion recovery
sequence) in identical slices. ECV calculation using the 5min (ECV1) and 15-20min
(ECV2) post-contrast T1 mapping were accomplished semi-automatically by
dedicated software. Native T1, ECV1 and ECV2 value of identical region of
interest (ROI) in interventricular septum were compared between amyloidosis
group and control group by Mann-Whitney test. Paired
ECV1 and ECV2 values in identical ROI were compared by Wilcoxon test.
Results: The amyloidosis group
recruited 26 patients (mean age
54±10 years, 13 men).11(42%)
of them had a positive endomyocardium biopsy confirmed by Congo red histology. The control group included 18
patients (mean age 41±12 years, 12 men). Myocardial native T1, ECV1 and ECV2
all significantly elevated in amyloidosis group compared to control group (1464±114ms
vs. 1267±40ms, 0.54±0.10 vs. 0.26±0.03, 0.51±0.09 vs. 0.26±0.03, p=0.000). In
amyloidosis group, ECV1 was slightly higher than ECV2 (0.54±0.10 vs. 0.51±0.09,
p=0.002), while in control groups ECV1 and ECV2 showed no significant
difference (0.26±0.03 vs. 0.26±0.03, p=0.925).
Conclusions:
Myocardial native T1,
ECV calculated by 5min and 15-20min post-contrast T1 mapping all
significantly elevated in cardiac amyloidosis patients in 3T CMR. ECV calculated
by 5min post-contrast T1 mapping showed similarly
promising diagnosis value for cardiac amyloidosis compared with 15-20 min
post-contrast T1 mapping.
Acknowledgements
No acknowledgement found.References
1.
Sanjay M. Banypersad, et al. Circ Cardiovasc Imaging.
2013;6:34-39.
2.
A. Barison, et al. J Intern Med. 2015 May;277(5):605-14.